Status:

COMPLETED

Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)

Lead Sponsor:

Takeda

Conditions:

Gastroesophageal Reflux

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Gastroesophageal reflux disease (GERD) is a medical condition affecting the stomach and esophagus. GERD occurs when the lower esophageal sphincter does not close properly and stomach contents leaks ba...

Eligibility Criteria

Inclusion

  • Main inclusion criteria:
  • In general good health other than gastroesophageal reflux disease (GERD)
  • History of GERD-related symptoms for at least 6 months prior to inclusion into the study
  • Endoscopically confirmed gastroesophageal reflux disease
  • Main exclusion criteria:
  • Acute peptic ulcer and/or ulcer complications
  • Systemic glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs) including COX-2-inhibitors on more than 3 consecutive days within the previous 28 days; except regular intake of acetylsalicylic acid in dosages up to 163 mg/day
  • Intake of Proton Pump Inhibitors and Histamine 2-receptor antagonists within the previous 14 days
  • Intake of psychotropic medication, dyspepsia-inducing drugs, and anticholinergic agents
  • Pregnant or nursing female patients; Non-pregnant, non-lactating female patients of childbearing potential who are not using reliable method of contraception

Exclusion

    Key Trial Info

    Start Date :

    November 1 2005

    Trial Type :

    INTERVENTIONAL

    End Date :

    November 1 2006

    Estimated Enrollment :

    600 Patients enrolled

    Trial Details

    Trial ID

    NCT00246909

    Start Date

    November 1 2005

    End Date

    November 1 2006

    Last Update

    May 7 2012

    Active Locations (51)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 13 (51 locations)

    1

    Altana Pharma/Nycomed

    Alabaster, Alabama, United States, 35007

    2

    Altana Pharma/Nycomed

    Huntsville, Alabama, United States, 35801

    3

    Altana Pharma/Nycomed

    Mesa, Arizona, United States, 85213

    4

    Altana Pharma/Nycomed

    Tucson, Arizona, United States, 85723